Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation / Liang, K; Esteva, Fj; Albarracin, C; Stemke-Hale, K; Lu, Y; Bianchini, G; Yang, Cy; Li, Y; Li, X; Chen, Ct; Mills, Gb; Hortobagyi, Gn; Mendelsohn, J; Hung, Mc; Fan, Z. - In: CANCER CELL. - ISSN 1535-6108. - (2010).
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
Bianchini G;
2010-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
